{
    "clinical_study": {
        "@rank": "54062", 
        "arm_group": [
            {
                "arm_group_label": "I", 
                "arm_group_type": "Active Comparator", 
                "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study"
            }, 
            {
                "arm_group_label": "II", 
                "arm_group_type": "Active Comparator", 
                "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study"
            }, 
            {
                "arm_group_label": "III", 
                "arm_group_type": "Active Comparator", 
                "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to learn how well atazanavir (ATV) works in combination with\n      ritonavir (RTV) or saquinavir (SQV) with tenofovir (TDF) and a nucleoside to reduce the\n      viral load of treatment experienced subjects with human immunodeficiency virus (HIV).  There\n      is a comparison arm with lopinavir (LPV)/RTV and TDF and a nucleoside."
        }, 
        "brief_title": "Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "ATV 300 mg / RTV"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "ATV 400 mg / SQV"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "LPV / RTV"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "120"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "115"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "123"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "358"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@lower_limit": "24", 
                                                "@upper_limit": "71", 
                                                "@value": "39"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@lower_limit": "26", 
                                                "@upper_limit": "74", 
                                                "@value": "41"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@lower_limit": "25", 
                                                "@upper_limit": "72", 
                                                "@value": "39"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@lower_limit": "24", 
                                                "@upper_limit": "74", 
                                                "@value": "40"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Full Range", 
                            "param": "Median", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "24"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "26"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "27"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "77"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "96"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "89"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "96"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "281"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "75"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "70"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "71"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "216"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "White"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "27"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "26"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "27"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "80"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Hispanic/Latino"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "18"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "16"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "21"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "55"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Black"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "7"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Other"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Race/Ethnicity, Customized", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "56"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "55"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "54"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "165"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "South America"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "39"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "38"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "47"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "124"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "North America"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "25"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "22"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "22"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "69"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Europe"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "33"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "33"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "36"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "102"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Yes"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "87"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "82"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "87"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "256"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "No"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Acquired Immunodeficiency Virus (AIDS)", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "8"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "8"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "23"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Yes"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "112"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "108"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "115"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "335"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "No"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Intravenous (IV) Drug Use", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@lower_limit": "40", 
                                                "@upper_limit": "1025", 
                                                "@value": "317"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@lower_limit": "42", 
                                                "@upper_limit": "1543", 
                                                "@value": "286"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@lower_limit": "14", 
                                                "@upper_limit": "1238", 
                                                "@value": "283"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@lower_limit": "14", 
                                                "@upper_limit": "1543", 
                                                "@value": "297"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Full Range", 
                            "param": "Median", 
                            "title": "Cluster of Differentiation 4 (CD4) cell count", 
                            "units": "cells/mm^3"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@lower_limit": "2.60", 
                                                "@upper_limit": "5.88", 
                                                "@value": "4.44"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@lower_limit": "2.60", 
                                                "@upper_limit": "5.88", 
                                                "@value": "4.42"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@lower_limit": "2.60", 
                                                "@upper_limit": "5.88", 
                                                "@value": "4.47"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@lower_limit": "2.60", 
                                                "@upper_limit": "5.88", 
                                                "@value": "4.45"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Full Range", 
                            "param": "Median", 
                            "title": "Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA)", 
                            "units": "log10 c/mL"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-0.09", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "0.37", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The time-averaged difference (TAD) in the reduction of log10 HIV RNA levels from baseline through Week 24 was compared pairwise for each atazanavir regimen to the lopinavir/RTV regimen, and assessed using a two-sided 97.5% confidence interval. The primary efficacy analysis was to declare two treatment regimens similar if the upper limit of this 97.5% confidence interval for the difference (atazanavir-lopinavir/RTV) was less than 0.5 log10.", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "0.14"
                                }, 
                                {
                                    "ci_lower_limit": "0.07", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "0.55", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The time-averaged difference (TAD) in the reduction of log10 HIV RNA levels from baseline through Week 24 was compared pairwise for each atazanavir regimen to the lopinavir/RTV regimen, and assessed using a two-sided 97.5% confidence interval. The primary efficacy analysis was to declare two treatment regimens similar if the upper limit of this 97.5% confidence interval for the difference (atazanavir-lopinavir/RTV) was less than 0.5 log10.", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "0.31"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.11", 
                                                        "@value": "-1.86"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.13", 
                                                        "@value": "-1.52"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.11", 
                                                        "@value": "-1.89"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Change From Baseline in HIV Ribonucleic Acid (RNA) at Week 24", 
                                    "units": "log10 c/mL"
                                }
                            ]
                        }, 
                        "population": "Randomized participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Mean Change From Baseline in HIV Ribonucleic Acid (RNA) at Week 24", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-0.04", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0.30", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Treatment Difference", 
                                    "param_value": "0.13"
                                }, 
                                {
                                    "ci_lower_limit": "-0.01", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0.35", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Treatment Difference", 
                                    "param_value": "0.17"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.06", 
                                                        "@value": "-1.18"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.07", 
                                                        "@value": "-1.14"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.06", 
                                                        "@value": "-1.30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Change From Baseline in HIV RNA at Week 2", 
                                    "units": "log10 c/mL"
                                }
                            ]
                        }, 
                        "population": "Treated participants, as-randomized (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 2", 
                        "title": "Mean Change From Baseline in HIV RNA at Week 2", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 24, by their baseline phenotypic sensitivity to their randomized PI.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "95"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "74"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "93"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Overall (n=120, 115, 123)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "79"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "58"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "72"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "PI Sensitive (n=88, 83, 88)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "16"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "15"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "19"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "PI Resistant (n=32, 30, 33)"
                                            }
                                        ]
                                    }, 
                                    "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 24, by their baseline phenotypic sensitivity to their randomized PI.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (Limit of Quantification [LOQ] = 400 c/mL) at Week 24 (Overall and by Protease Inhibitor [PI] Sensitivity)", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Number of Participants Analyzed=Randomized participants; as-randomized population (refers to the treatment regimen assigned at randomization); n=number of evaluable (overall, PI sensitive, PI resistant) participants.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Participants Achieving Virologic Half Log Suppression (Limit of Quantification [LOQ] = 400 c/mL) at Week 24 (Overall and by Protease Inhibitor [PI] Sensitivity)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 48, by their baseline phenotypic sensitivity to their randomized PI.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "77"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "60"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "84"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Overall (n=120, 115, 123)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "65"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "52"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "67"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "PI Sensitive (n=88, 84, 88)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "12"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "7"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "16"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "PI Resistant (n=32, 30, 33)"
                                            }
                                        ]
                                    }, 
                                    "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 48, by their baseline phenotypic sensitivity to their randomized PI.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 400 c/mL) at Week 48, (Overall and by PI Sensitivity)", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Number of Participants Analyzed=Randomized participants; as-randomized population (refers to the treatment regimen assigned at randomization).n=number of evaluable (overall, PI sensitive, PI resistant) participants.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 400 c/mL) at Week 48, (Overall and by PI Sensitivity)", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-0.12", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "0.39", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "0.13"
                                }, 
                                {
                                    "ci_lower_limit": "0.07", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "0.60", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Time-Averaged Distance", 
                                    "param_value": "0.33"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.12", 
                                                        "@value": "-1.93"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.14", 
                                                        "@value": "-1.55"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.13", 
                                                        "@value": "-1.87"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Change From Baseline in HIV RNA at Week 48", 
                                    "units": "log10 c/mL"
                                }
                            ]
                        }, 
                        "population": "Randomized participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Mean Change From Baseline in HIV RNA at Week 48", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-13.3", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "12.3", 
                                "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "Randomized participants", 
                                "non_inferiority": "No", 
                                "param_type": "Difference estimate", 
                                "param_value": "-0.5"
                            }
                        }, 
                        "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 96.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "113"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "61"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "58"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 96.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 400 c/mL) at Week 96", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Observed case analysis: Randomized participants (while on initial regimen--completers censored) with baseline and on-study measurement.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 96", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 400 c/mL) at Week 96", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-7.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "14.1", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "3.6"
                                }, 
                                {
                                    "ci_lower_limit": "-22.9", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0.4", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-11.3"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "95"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "74"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "93"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 24", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 24", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 50 c/mL at Week 24, by their baseline phenotypic sensitivity to their randomized PI.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }, 
                                                    {
                                                        "@group_id": "O3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 50 c/mL at Week 24, by their baseline phenotypic sensitivity to their randomized PI.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 24, by PI Sensitivity", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "As there were multiple efficacy algorithms run and multiple subsets analyzed, it was decided to only use LOQ < 50 on the primary endpoint, and to run LOQ<400 for subsets such as baseline PI sensitivity.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 24, by PI Sensitivity", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-16.9", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "7.0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-5.0"
                                }, 
                                {
                                    "ci_lower_limit": "-28.5", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-3.7", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-16.1"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "76"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "84"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 48", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 48", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 50 c/mL at Week 48, by their baseline phenotypic sensitivity to their randomized PI.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }, 
                                                    {
                                                        "@group_id": "O3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 50 c/mL at Week 48, by their baseline phenotypic sensitivity to their randomized PI.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 48, by PI Sensitivity", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "As there were multiple efficacy algorithms run and multiple subsets analyzed, it was decided to only use LOQ < 50 on the primary endpoint, and to run LOQ<400 for subsets such as baseline PI sensitivity.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 48, by PI Sensitivity", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-12.5", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "13.2", 
                                "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "non_inferiority": "No", 
                                "param_type": "Difference Estimate", 
                                "param_value": "0.4"
                            }
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "113"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "61"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "57"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 96", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants while on initial regimen (completers censored).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 96", 
                        "title": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 96", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-9.1", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "15.4", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "3.2"
                                }, 
                                {
                                    "ci_lower_limit": "-29.4", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-4.0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-16.7"
                                }
                            ]
                        }, 
                        "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "76"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "74"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 24", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants while on initial regimen Randomized participants, (completers censored).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 24", 
                        "title": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-13.7", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "11.4", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-1.1"
                                }, 
                                {
                                    "ci_lower_limit": "-30.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-5.3", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-17.9"
                                }
                            ]
                        }, 
                        "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "64"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "42"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "67"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 48", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants, as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "Yes", 
                        "time_frame": "Week 48", 
                        "title": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-15.0", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "10.3", 
                                "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "non_inferiority": "No", 
                                "param_type": "Difference Estimate", 
                                "param_value": "-2.4"
                            }
                        }, 
                        "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "116"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "52"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "53"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 96", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants while on initial regimen (completers censored).", 
                        "safety_issue": "Yes", 
                        "time_frame": "Week 96", 
                        "title": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 96", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-14.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "10.0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-2.3"
                                }, 
                                {
                                    "ci_lower_limit": "-30.7", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-7.1", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-18.9"
                                }
                            ]
                        }, 
                        "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "46"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "25"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 24", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants, as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 24", 
                        "title": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-18.7", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "5.8", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-6.4"
                                }, 
                                {
                                    "ci_lower_limit": "-29.9", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-5.9", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-17.9"
                                }
                            ]
                        }, 
                        "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "43"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "28"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "52"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 48", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participantsRandomized participants while on initial regimen (completers censored).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 48", 
                        "title": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "38"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "41"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                                    "param": "Number", 
                                    "title": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 96", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants while on initial regimen (completers censored)", 
                        "safety_issue": "Yes", 
                        "time_frame": "Week 96", 
                        "title": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 96", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-44.3", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "7.5", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "-18.4"
                                }, 
                                {
                                    "ci_lower_limit": "-74.5", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "-15.3", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "-44.9"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "14.0", 
                                                        "@value": "83"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "11.8", 
                                                        "@value": "59"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "15.3", 
                                                        "@value": "90"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline in CD4 Cell Count at Week 24", 
                                    "units": "cells/mm3"
                                }
                            ]
                        }, 
                        "population": "Randomized participantsRandomized participants while on initial regimen (completers censored).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Change From Baseline in CD4 Cell Count at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-45.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "10.6", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "-17.5"
                                }, 
                                {
                                    "ci_lower_limit": "-79.2", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "-16.1", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Time-Averaged Difference", 
                                    "param_value": "-47.6"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "22.9", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "19.7", 
                                                        "@value": "72"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "20.1", 
                                                        "@value": "121"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline in CD4 Cell Count at Week 48", 
                                    "units": "cells/mm3"
                                }
                            ]
                        }, 
                        "population": "Randomized participants while on initial regimen (completers censored).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Change From Baseline in CD4 Cell Count at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "60"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "26.3", 
                                                        "@value": "122"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "24.2", 
                                                        "@value": "154"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline in CD4 Cell Count at Week 96", 
                                    "units": "cells/mm3"
                                }
                            ]
                        }, 
                        "population": "Randomized participants (while on initial regimen) with evaluation at time point", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 96", 
                        "title": "Change From Baseline in CD4 Cell Count at Week 96", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "group_id_list": {
                                        "group_id": "O1"
                                    }, 
                                    "groups_desc": "Correlation between IQ (<10; >=10) of ATV 300 mg / RTV and HIV RNA", 
                                    "method": "t-test, 1 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.05", 
                                    "p_value_desc": "P-value was based on a t-distribution."
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": "O2"
                                    }, 
                                    "groups_desc": "Correlation between number of PI Mutations at baseline (<4; >=4) of ATV 400 mg / SQV and HIV RNA", 
                                    "method": "t-test, 1 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.05", 
                                    "p_value_desc": "P-value was based on a t-distribution."
                                }
                            ]
                        }, 
                        "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with HIV RNA change from baseline at Week 24 were explored.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice treated participants (HIV RNA change from baseline [log10 c/mL] Mean [SE] = -1.91 [0.19])", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice treated participants (HIV RNA change from baseline [log10 c/mL] Mean [SE] = -1.57 [0.3])", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "23"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-0.056"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0.254"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "ATV Cmin"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-0.391"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-0.081"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "IQ (<10; >=10)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0.306"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0.437"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "# of PI Mutations at baseline (<4; >=4)"
                                            }
                                        ]
                                    }, 
                                    "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with HIV RNA change from baseline at Week 24 were explored.", 
                                    "param": "Number", 
                                    "title": "Correlation of ATV Minimum Plasma Concentration (Cmin), Inhibitory Quotient (IQ), and Number of Protease Inhibitor (PI) Mutations at Baseline With HIV RNA Change From Baseline at Week 24", 
                                    "units": "Pearson Correlation Coefficient"
                                }
                            ]
                        }, 
                        "population": "Week 24: Participants with evaluable PK measurements", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Correlation of ATV Minimum Plasma Concentration (Cmin), Inhibitory Quotient (IQ), and Number of Protease Inhibitor (PI) Mutations at Baseline With HIV RNA Change From Baseline at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with HIV RNA change from baseline at Week 48 were explored.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice treated participants (HIV RNA change from baseline [log10 c/mL] Mean [SE] = -1.91 [0.19])", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice treated participants (HIV RNA change from baseline [log10 c/mL] Mean [SE] = -1.57 [0.3])", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with HIV RNA change from baseline at Week 48 were explored.", 
                                    "param": "Number", 
                                    "title": "Correlation of ATV Minimum Plasma Concentration (Cmin), Inhibitory Quotient (IQ), and Number of Protease Inhibitor (PI) Mutations at Baseline With HIV RNA Change From Baseline at Week 48", 
                                    "units": "Pearson Correlation Coefficient"
                                }
                            ]
                        }, 
                        "population": "Formal population PK/PD analysis was not performed due to difficulties in correlating time of blood sample collection with drug administration, and inability to apply the PK model generated with data obtained from healthy subjects due to newly observed differences in exposure to atazanavir between HIV-infected participants and healthy participants.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Correlation of ATV Minimum Plasma Concentration (Cmin), Inhibitory Quotient (IQ), and Number of Protease Inhibitor (PI) Mutations at Baseline With HIV RNA Change From Baseline at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "group_id_list": {
                                        "group_id": "O1"
                                    }, 
                                    "groups_desc": "Correlation between ATV Cmin of ATV 300 mg / RTV and CD4 Cell Count", 
                                    "method": "t-test, 1 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.05", 
                                    "p_value_desc": "P-value was based on a t-distribution."
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": "O1"
                                    }, 
                                    "groups_desc": "Correlation between IQ (<10; >=10) of ATV 300 mg / RTV and CD4 Cell Count", 
                                    "method": "t-test, 1 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.05", 
                                    "p_value_desc": "P-value was based on a t-distribution."
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": "O1"
                                    }, 
                                    "groups_desc": "Correlation between # of PI Mutations at baseline (<4; >=4) of ATV 300 mg / RTV and CD4 Cell Count", 
                                    "method": "t-test, 1 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.05", 
                                    "p_value_desc": "P-value was based on a t-distribution."
                                }
                            ]
                        }, 
                        "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with CD4 cell count change from baseline at Week 24 were explored.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice treated participants (CD4 Cell Count Change from Baseline [cells/mm3] Mean [SE] = 80 [21])", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice treated participants (HIV RNA change from baseline [log10 c/mL] Mean [SE] = 56 [20])", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "23"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0.37"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-0.21"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "ATV Cmin"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0.376"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0.105"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "IQ (<10; >=10)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-0.395"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-0.227"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "# of PI Mutations at baseline (<4; >=4)"
                                            }
                                        ]
                                    }, 
                                    "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with CD4 cell count change from baseline at Week 24 were explored.", 
                                    "param": "Number", 
                                    "title": "Correlation of ATV Minimum Plasma Concentration (Cmin) Inhibitory Quotient (IQ), and Number of PI Mutations at Baseline and CD4 Cell Count Change From Baseline at Week 24", 
                                    "units": "Pearson Correlation Coefficient"
                                }
                            ]
                        }, 
                        "population": "Participants with evaluable PK measurements, as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Correlation of ATV Minimum Plasma Concentration (Cmin) Inhibitory Quotient (IQ), and Number of PI Mutations at Baseline and CD4 Cell Count Change From Baseline at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with CD4 cell count change from baseline at Week 48 were explored.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice treated participants (CD4 Cell Count Change from Baseline [cells/mm3] Mean [SE] = 80 [21])", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice treated participants (HIV RNA change from baseline [log10 c/mL] Mean [SE] = 56 [20])", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with CD4 cell count change from baseline at Week 48 were explored.", 
                                    "param": "Number", 
                                    "title": "Correlation of ATV Minimum Plasma Concentration (Cmin) Inhibitory Quotient (IQ), and Number of PI Mutations at Baseline and CD4 Cell Count Change From Baseline at Week 48", 
                                    "units": "Pearson Correlation Coefficient"
                                }
                            ]
                        }, 
                        "population": "Formal population PK/PD analysis was not performed due to difficulties in correlating time of blood sample collection with drug administration, and inability to apply the PK model generated with data obtained from healthy subjects due to newly observed differences in exposure to atazanavir between HIV-infected participants and healthy participants.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Correlation of ATV Minimum Plasma Concentration (Cmin) Inhibitory Quotient (IQ), and Number of PI Mutations at Baseline and CD4 Cell Count Change From Baseline at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-15.5", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-6.0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Total Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-10.9"
                                }, 
                                {
                                    "ci_lower_limit": "-16.9", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-7.6", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Total Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-12.4"
                                }, 
                                {
                                    "ci_lower_limit": "-13.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0.7", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "HDL cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-6.7"
                                }, 
                                {
                                    "ci_lower_limit": "-9.3", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "8.1", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "HDL Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-1.0"
                                }, 
                                {
                                    "ci_lower_limit": "-15.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "3.0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting LDL Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-6.8"
                                }, 
                                {
                                    "ci_lower_limit": "-15.5", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "1.8", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting LDL Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-7.3"
                                }, 
                                {
                                    "ci_lower_limit": "-35.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-13.2", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting Triglycerides", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-24.9"
                                }, 
                                {
                                    "ci_lower_limit": "-43.4", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-23.4", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting Triglycerides", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-34.2"
                                }
                            ]
                        }, 
                        "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-9"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Total Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "High Density Lipoprotein (HDL) Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-10"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-11"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "-4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fasting Low Density Lipoprotein (LDL) Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-14"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "31"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fasting Triglycerides"
                                            }
                                        ]
                                    }, 
                                    "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                                    "param": "Number", 
                                    "title": "Lipid Mean Percent Change From Baseline at Week 24", 
                                    "units": "percent change"
                                }
                            ]
                        }, 
                        "population": "Treated Participants, Last Observation Carried Forward (LOCF), as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Lipid Mean Percent Change From Baseline at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-17.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-7.2", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Total Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-12.1"
                                }, 
                                {
                                    "ci_lower_limit": "-17.4", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-6.5", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Total Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-12.0"
                                }, 
                                {
                                    "ci_lower_limit": "-12.4", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "3.5", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "HDL Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-4.4"
                                }, 
                                {
                                    "ci_lower_limit": "-11.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "9.3", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "HDL Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "DIfference Estimate", 
                                    "param_value": "-0.8"
                                }, 
                                {
                                    "ci_lower_limit": "-19.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "1.2", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting LDL CHolesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-8.9"
                                }, 
                                {
                                    "ci_lower_limit": "-17.7", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "3.0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting LDL Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-7.4"
                                }, 
                                {
                                    "ci_lower_limit": "-41.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-17.7", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting Triglycerides", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-29.6"
                                }, 
                                {
                                    "ci_lower_limit": "-49.7", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-27.1", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Fasting Triglycerides", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-38.4"
                                }
                            ]
                        }, 
                        "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-4"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "6"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Total Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "HDL Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-10"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fasting LDL Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-14"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fasting Triglycerides"
                                            }
                                        ]
                                    }, 
                                    "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                                    "param": "Number", 
                                    "title": "Lipid Mean Percent Change From Baseline at Week 48", 
                                    "units": "percent change in lipid values"
                                }
                            ]
                        }, 
                        "population": "Treated Participants, Last Observation Carried Forward (LOCF); as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 48", 
                        "title": "Lipid Mean Percent Change From Baseline at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-20.1", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-8.3", 
                                    "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Observed values, Total Cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-14.4"
                                }, 
                                {
                                    "ci_lower_limit": "-16.1", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-1.3", 
                                    "estimate_desc": "ATV 400/SQV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "observed values, total cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-9.0"
                                }, 
                                {
                                    "ci_lower_limit": "-19.9", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-1.2", 
                                    "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "observed values, HDL cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-11.0"
                                }, 
                                {
                                    "ci_lower_limit": "-14.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "7.0", 
                                    "estimate_desc": "ATV 400/SQV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Observed values, HDL cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-4.1"
                                }, 
                                {
                                    "ci_lower_limit": "-22.3", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-1.8", 
                                    "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "observed cases, fasting LDL", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-12.7"
                                }, 
                                {
                                    "ci_lower_limit": "-19.0", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "4.8", 
                                    "estimate_desc": "ATV 400/SQV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "Observed Cases, Fasting LDL cholesterol", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-7.9"
                                }, 
                                {
                                    "ci_lower_limit": "-38.6", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-8.0", 
                                    "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "observed cases, fasting triglycerides", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-24.8"
                                }, 
                                {
                                    "ci_lower_limit": "-36.5", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "1.3", 
                                    "estimate_desc": "ATV 400/SQV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "observed cases, fasting triglycerides", 
                                    "non_inferiority": "No", 
                                    "param_type": "Difference Estimate", 
                                    "param_value": "-19.8"
                                }
                            ]
                        }, 
                        "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "9"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Total Cholesterol (n=60, 46, 54)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "HDL Cholesterol (n=60, 46, 54)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-11"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "-7"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fasting LDL Cholesterol (n=52, 39, 43)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "-2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fasting Triglycerides (n=52, 40, 43)"
                                            }
                                        ]
                                    }, 
                                    "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                                    "param": "Number", 
                                    "title": "Lipid Mean Percent Change From Baseline at Week 96, Observed Values", 
                                    "units": "percent change in lipid values"
                                }
                            ]
                        }, 
                        "population": "Treated Participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 96", 
                        "title": "Lipid Mean Percent Change From Baseline at Week 96, Observed Values", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "AE=any new untoward medical occurrence/worsening of a pre-existing medical condition regardless of causal relationship. SAE=any untoward medical occurrence at any dose that: results in death; is life-threatening; requires/prolongs inpatient hospitalization; results in persistent/significant disability; is cancer; is congenital anomaly/birth defect; results in drug dependency/abuse; is an important medical event.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "120"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "123"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Deaths (n = 120, 115, 123)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "AEs leading to discontinuation (n = 119, 110, 118)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "12"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "14"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "11"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "SAEs (n = 120, 115, 123)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "97"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "93"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "103"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "AEs, grades 1-4 (n = 119, 110, 118)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "11"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "18"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "12"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "AEs, grades 3-4 (n = 119, 110, 118)"
                                            }
                                        ]
                                    }, 
                                    "description": "AE=any new untoward medical occurrence/worsening of a pre-existing medical condition regardless of causal relationship. SAE=any untoward medical occurrence at any dose that: results in death; is life-threatening; requires/prolongs inpatient hospitalization; results in persistent/significant disability; is cancer; is congenital anomaly/birth defect; results in drug dependency/abuse; is an important medical event.", 
                                    "param": "Number", 
                                    "title": "Deaths, Serious Adverse Events (SAEs), and Adverse Events (AEs) Through Week 48", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Randomized participants for Deaths and SAEs; treated participants for all others; as-randomized population (refers to the treatment regimen assigned at randomization). In addition, of the 213 screen failures (not randomized), there were 4 subjects who had an SAE; these are not included in the table below.", 
                        "safety_issue": "Yes", 
                        "time_frame": "From Enrollment through Week 48", 
                        "title": "Deaths, Serious Adverse Events (SAEs), and Adverse Events (AEs) Through Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Prespecified AEs of interest included jaundice, ocular icterus, and hyperbilirubinemia.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "25"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "29"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "54"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Diarrhea (Most Common)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "21"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "24"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "18"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Headache (Most Common)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "19"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "24"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "15"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Nausea (Most Common)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "19"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Jaundice (AE of Interest)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "13"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Ocular Icterus (AE of Interest)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "24"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Hyperbilirubinemia (AE of Interest)"
                                            }
                                        ]
                                    }, 
                                    "description": "Prespecified AEs of interest included jaundice, ocular icterus, and hyperbilirubinemia.", 
                                    "param": "Number", 
                                    "title": "Most Common AEs and AEs of Interest Through Week 48", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Treated participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "Yes", 
                        "time_frame": "From Enrollment to Week 48", 
                        "title": "Most Common AEs and AEs of Interest Through Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "104"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "87"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "99"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "1.6", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "1.8", 
                                                        "@value": "-3"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "1.4", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Fasting Glucose Mean Change From Baseline at Week 24", 
                                    "units": "mg/dL"
                                }
                            ]
                        }, 
                        "population": "Treated Participants with evaluation at time point; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Fasting Glucose Mean Change From Baseline at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "115"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "108"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "112"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "3.6", 
                                                        "@value": "4"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "1.6", 
                                                        "@value": "-1"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "1.5", 
                                                        "@value": "1"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Fasting Glucose Mean Change From Baseline at Week 48", 
                                    "units": "mg/dL"
                                }
                            ]
                        }, 
                        "population": "Treated Participants with evaluation at time point; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 48", 
                        "title": "Fasting Glucose Mean Change From Baseline at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Grades:1=Mild, 2=Moderate, 3=Severe, 4=Life-threatening/disabling, 5=Death. Abnormal values: absolute neutrophil count: \u2265500 to <750/mm3 (grade 3), <500/mm3 (grade 4); platelets: 20,000-49,999/mm3 (grade 3), <20,000/mm3 or diffuse petechiae (grade 4); alanine transaminase (ALT): 5.1-10 x upper limit of normal (ULN; grade 3), >10 x ULN (grade 4); aspartate transaminase (AST):  5.1-10 x ULN (grade 3), >10 x ULN (grade 4); bilirubin: 2.6-5 x ULN (grade 3), >5 x ULN (grade 4).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "108"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "10"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Neutrophil Reduction"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Platelet Reduction"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "ALT Elevation"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "AST Elevation"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "58"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "22"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Total Bilirubin Elevation"
                                            }
                                        ]
                                    }, 
                                    "description": "Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Grades:1=Mild, 2=Moderate, 3=Severe, 4=Life-threatening/disabling, 5=Death. Abnormal values: absolute neutrophil count: \u2265500 to <750/mm3 (grade 3), <500/mm3 (grade 4); platelets: 20,000-49,999/mm3 (grade 3), <20,000/mm3 or diffuse petechiae (grade 4); alanine transaminase (ALT): 5.1-10 x upper limit of normal (ULN; grade 3), >10 x ULN (grade 4); aspartate transaminase (AST):  5.1-10 x ULN (grade 3), >10 x ULN (grade 4); bilirubin: 2.6-5 x ULN (grade 3), >5 x ULN (grade 4).", 
                                    "param": "Number", 
                                    "title": "Grade 3/4 Laboratory Abnormalities Through Week 48", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Evaluable treated participants; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "Yes", 
                        "time_frame": "From Enrollment to Week 48", 
                        "title": "Grade 3/4 Laboratory Abnormalities Through Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The QT interval is a measure of the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle. The QT interval was corrected for heart rate using Fridericia's (QTcF) formula.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.9", 
                                                            "@value": "390"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.2", 
                                                            "@value": "387"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.9", 
                                                            "@value": "390"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Baseline Mean (n=119, 110, 118)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.6", 
                                                            "@value": "-3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.9", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.7", 
                                                            "@value": "-2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 4 predose (n=117, 104, 110)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.6", 
                                                            "@value": "-2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.0", 
                                                            "@value": "-3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.9", 
                                                            "@value": "-7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change Wk 4 2-3 hrs postdose (n=113,102,106)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.7", 
                                                            "@value": "-4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.9", 
                                                            "@value": "-1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.8", 
                                                            "@value": "-8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change Wk 4 6-12 hrs postdose (n=112,101,105)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.6", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.0", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.6", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 12 (n=110, 97, 107)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.8", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.2", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.8", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 24 (n=108, 92, 109)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.8", 
                                                            "@value": "-1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.1", 
                                                            "@value": "-1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "2.0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 48 (n=89, 75, 97)"
                                            }
                                        ]
                                    }, 
                                    "description": "The QT interval is a measure of the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle. The QT interval was corrected for heart rate using Fridericia's (QTcF) formula.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Fridericia-corrected QT (QTcF) Interval and Change From Baseline by Analysis Time Point", 
                                    "units": "msec"
                                }
                            ]
                        }, 
                        "population": "Treated participants; as-randomized population (refers to the treatment regimen assigned at randomization). n=number of participants evaluated at timepoint", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 4 predose, 2-3 hours postdose, 6-12 hours postdose, Week 12, Week 24, Week 48", 
                        "title": "Fridericia-corrected QT (QTcF) Interval and Change From Baseline by Analysis Time Point", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The PR interval is measured from the beginning of the P wave to the beginning of the QRS complex, and reflects the time the electrical impulse takes to travel from the sinus node through the atrioventricular (AV) node and entering the ventricles. The PR interval is therefore a good estimate of AV node function.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.7", 
                                                            "@value": "153"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.9", 
                                                            "@value": "155"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.7", 
                                                            "@value": "154"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Baseline Mean (n=119, 110, 118)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.2", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.6", 
                                                            "@value": "9"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.4", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 4 predose (n=117, 104, 110)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.3", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.6", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.7", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change Wk 4 2-3 hrs postdose (n=113,102,106)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.4", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.7", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.5", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change Wk 4 6-12 hrs postdose (n=112,101,105)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.6", 
                                                            "@value": "5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.7", 
                                                            "@value": "7"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.4", 
                                                            "@value": "8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 12 (n=110, 97, 107)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.3", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.7", 
                                                            "@value": "7"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.6", 
                                                            "@value": "5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 24 (n=108, 92, 109)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.5", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.9", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.7", 
                                                            "@value": "4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mean Change at Week 48 (n=89, 75, 97)"
                                            }
                                        ]
                                    }, 
                                    "description": "The PR interval is measured from the beginning of the P wave to the beginning of the QRS complex, and reflects the time the electrical impulse takes to travel from the sinus node through the atrioventricular (AV) node and entering the ventricles. The PR interval is therefore a good estimate of AV node function.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "PR Interval and Change From Baseline by Analysis Time Point", 
                                    "units": "msec"
                                }
                            ]
                        }, 
                        "population": "Treated participants; as-randomized population (refers to the treatment regimen assigned at randomization). n=number of participants evaluated at timepoint", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 4 predose, 2-3 hours postdose, 6-12 hours postdose, Week 12, Week 24, Week 48", 
                        "title": "PR Interval and Change From Baseline by Analysis Time Point", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The MACS adherence questionnaire asks patients how many medication doses they missed during the previous day, 2 days, 3 days and 4 days. Drug-specific questions included adherence with dose and frequency. Adherence was defined as taking all doses and numbers of pills as prescribed for each medication. This strict adherence cut-off was based on the guidelines stating that anything less than excellent adherence may result in a virus breakthrough and development of resistance.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "33"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "48"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "12"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "10"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "18"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Adherent at Baseline (n=27, 25, 33)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "10"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "5"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "23"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Adherent at Week 24 (n=18, 11, 25)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "13"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Adherent at Week 48 (n=11, 4, 20)"
                                            }
                                        ]
                                    }, 
                                    "description": "The MACS adherence questionnaire asks patients how many medication doses they missed during the previous day, 2 days, 3 days and 4 days. Drug-specific questions included adherence with dose and frequency. Adherence was defined as taking all doses and numbers of pills as prescribed for each medication. This strict adherence cut-off was based on the guidelines stating that anything less than excellent adherence may result in a virus breakthrough and development of resistance.", 
                                    "param": "Number", 
                                    "title": "Adherence to Regimen Though Week 48 Based on MACS the Multicenter AIDS Cohort Study (MACS) Adherence Questionnaire", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Number of Participants Analyzed=treated participants; as-randomized population (refers to the treatment regimen assigned at randomization); n=subset of treated participants (Given the language limitation, a subset of the AI424045 population was included in the MACS adherence analysis.)", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24, Week 48", 
                        "title": "Adherence to Regimen Though Week 48 Based on MACS the Multicenter AIDS Cohort Study (MACS) Adherence Questionnaire", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The EQ-5D is a 5-item questionnaire to assess health-related quality of life in 5 health dimensions (mobility, self-care, usual activity, pain/discomfort, anxiety/depression) are scored on a 3-level scale: no problems (1), some problems (2), extreme problems (3). Using a standard algorithm, responses are summarized into a single score, the EQ-5D Health Index Score (HIS), which ranges between 1 (representing perfect health) and 0 (representing the worst imaginable health state or death). The smallest coefficient of change is 0.03.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.83"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.85"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.86"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Baseline  (n=99, 86, 100)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.87"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.86"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "0.01", 
                                                            "@value": "0.89"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mid-Study (n=103, 83, 95)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.84"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.03", 
                                                            "@value": "0.85"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "0.02", 
                                                            "@value": "0.88"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Final (n=93, 84, 96)"
                                            }
                                        ]
                                    }, 
                                    "description": "The EQ-5D is a 5-item questionnaire to assess health-related quality of life in 5 health dimensions (mobility, self-care, usual activity, pain/discomfort, anxiety/depression) are scored on a 3-level scale: no problems (1), some problems (2), extreme problems (3). Using a standard algorithm, responses are summarized into a single score, the EQ-5D Health Index Score (HIS), which ranges between 1 (representing perfect health) and 0 (representing the worst imaginable health state or death). The smallest coefficient of change is 0.03.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Score of European Quality of Life-5 Dimensions (EQ-5D) Health Index Score at Baseline, Mid-Study (Week 24), and Final (Week 48)", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Treated participants; as-randomized population (refers to the treatment regimen assigned at randomization). n=number of participants evaluated with EQ-5D at given time point.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24, Week 48", 
                        "title": "Mean Score of European Quality of Life-5 Dimensions (EQ-5D) Health Index Score at Baseline, Mid-Study (Week 24), and Final (Week 48)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The EQ-5D has a Visual Analog Scale (VAS), which is a feeling thermometer-like scale with a range between 0 and 100. Patients are required to draw a line from a box on the VAS scale to an actual mark on the thermometer-like scale that corresponds with a number that reflects their self-assessed health status at the time they are completing the questionnaire. Higher VAS scores indicate better overall health. There is no minimum clinically important difference reported in the literature for VAS.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "119"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "118"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.63", 
                                                            "@value": "81.33"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.77", 
                                                            "@value": "81.72"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.53", 
                                                            "@value": "81.52"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Baseline  (n=98, 85, 101)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.65", 
                                                            "@value": "84.89"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.89", 
                                                            "@value": "83.34"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.55", 
                                                            "@value": "85.09"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mid-Study (n=102, 83, 97)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.72", 
                                                            "@value": "82.77"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.64", 
                                                            "@value": "85.80"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.36", 
                                                            "@value": "86.16"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Final (n=95, 81, 96)"
                                            }
                                        ]
                                    }, 
                                    "description": "The EQ-5D has a Visual Analog Scale (VAS), which is a feeling thermometer-like scale with a range between 0 and 100. Patients are required to draw a line from a box on the VAS scale to an actual mark on the thermometer-like scale that corresponds with a number that reflects their self-assessed health status at the time they are completing the questionnaire. Higher VAS scores indicate better overall health. There is no minimum clinically important difference reported in the literature for VAS.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Score of European Quality of Life-5 Dimensions (EQ-5D) Visual Analog Scale (VAS) at Baseline, Mid-Study (Week 24), and Final (Week 48)", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Treated participants; as-randomized population (refers to the treatment regimen assigned at randomization). n=number of participants evaluated with EQ-5D at given time point.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24, Week 48", 
                        "title": "Mean Score of European Quality of Life-5 Dimensions (EQ-5D) Visual Analog Scale (VAS) at Baseline, Mid-Study (Week 24), and Final (Week 48)", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-0.13", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "0.41", 
                                    "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "groups_desc": "overall", 
                                    "non_inferiority": "No", 
                                    "param_type": "time-averaged difference", 
                                    "param_value": "0.14"
                                }, 
                                {
                                    "ci_lower_limit": "-0.16", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "97.5", 
                                    "ci_upper_limit": "0.38", 
                                    "estimate_desc": "ATV 300/RTV - LPV/RTV", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "groups_desc": "last observation carried forward", 
                                    "non_inferiority": "No", 
                                    "param_type": "time-averaged difference", 
                                    "param_value": "0.11"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "64"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "65"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.121", 
                                                        "@value": "-2.29"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.151", 
                                                        "@value": "-2.08"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Change From Baseline in HIV RNA at Week 96", 
                                    "units": "log10 c/mL"
                                }
                            ]
                        }, 
                        "population": "Randomized participants while on initial regimen", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 96", 
                        "title": "Mean Change From Baseline in HIV RNA at Week 96", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Participants' overall resource utilization for managing lipid elevation that includes the management of side effects of lipid lowering medications, such as those due to drug interactions.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "LPV/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "LPV / RTV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }, 
                                                    {
                                                        "@group_id": "O3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Participants' overall resource utilization for managing lipid elevation that includes the management of side effects of lipid lowering medications, such as those due to drug interactions.", 
                                    "param": "Number", 
                                    "title": "Number of Participants Utilizing Resources for Managing Lipid Elevation", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Although the intent of this planned analysis was to provide a model of economic value for Lipid Management, a different approach was taken to create this model which did not require data from this trial, and thus this analysis was not done.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24, Week 48", 
                        "title": "Number of Participants Utilizing Resources for Managing Lipid Elevation", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The minimum or \"trough\" concentration (Cmin) of a drug observed after its administration and just prior to the administration of a subsequent dose.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "23"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "82.81", 
                                                            "@value": "719.53"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "145.31", 
                                                            "@value": "312.01"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "ATV (n=40,23)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "39.31", 
                                                            "@value": "154.83"
                                                        }, 
                                                        {
                                                            "#text": "No participants were analyzed in this cohort for RTV because they did not take this drug.", 
                                                            "@group_id": "O2", 
                                                            "@spread": "NA", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "RTV (n=40,0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "#text": "No participants were analyzed in this cohort for SQV because they did not take this drug.", 
                                                            "@group_id": "O1", 
                                                            "@spread": "NA", 
                                                            "@value": "NA"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "16.89", 
                                                            "@value": "52.15"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "SQV (n=0,19)"
                                            }
                                        ]
                                    }, 
                                    "description": "The minimum or \"trough\" concentration (Cmin) of a drug observed after its administration and just prior to the administration of a subsequent dose.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean ATV, RTV and SQV Minimum Concentration (Cmin) Values", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Participants with evaluable Cmins; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "collected at the pre-dose time point after receiving atazanavir for at least four weeks", 
                        "title": "Mean ATV, RTV and SQV Minimum Concentration (Cmin) Values", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "IC50:   inhibitory concentration of drug required to reduce viral replication by 50%.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "21"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "4.04", 
                                                        "@value": "17.83"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "11.65", 
                                                        "@value": "22.84"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "IC50:   inhibitory concentration of drug required to reduce viral replication by 50%.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "HIV IC50 at Week 24", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Participants with evaluable IC50 measurements; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Week 24", 
                        "title": "HIV IC50 at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Inhibitory quotient is a measure of drug exposure and susceptibility in an individual. The IQ is typically calculated as the ratio of Cmin to HIV IC50.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "21"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "24.33", 
                                                        "@value": "136.94"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "13.33", 
                                                        "@value": "25.04"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Inhibitory quotient is a measure of drug exposure and susceptibility in an individual. The IQ is typically calculated as the ratio of Cmin to HIV IC50.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Inhibitory Quotient at Week 24", 
                                    "units": "ratio"
                                }
                            ]
                        }, 
                        "population": "Participants with evaluable IQ measurements (ie, must have both Cmin and IC50 measurements); as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "Inhibitory Quotient at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Inhibitory quotient is a measure of drug exposure and susceptibility in an individual. The IQ is typically calculated as the ratio of Cmin to HIV IC50.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Inhibitory quotient is a measure of drug exposure and susceptibility in an individual. The IQ is typically calculated as the ratio of Cmin to HIV IC50.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Inhibitory Quotient at Week 48", 
                                    "units": "ratio"
                                }
                            ]
                        }, 
                        "population": "Formal population PK/PD analysis was not performed due to difficulties in correlating time of blood sample collection with drug administration, and inability to apply the PK model generated with data obtained from healthy subjects due to newly observed differences in exposure to atazanavir between HIV-infected participants and healthy participants.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "Inhibitory Quotient at Week 48", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Week 24 HIV RNA level and change from baseline were summarized for treated subjects with evaluable Cmins.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "40"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "23"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.13", 
                                                            "@value": "4.53"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.13", 
                                                            "@value": "4.41"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Baseline Values"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.19", 
                                                            "@value": "2.62"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.25", 
                                                            "@value": "2.83"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 24 Values"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.19", 
                                                            "@value": "-1.91"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.29", 
                                                            "@value": "-1.57"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Change from Baseline at Week 24"
                                            }
                                        ]
                                    }, 
                                    "description": "Week 24 HIV RNA level and change from baseline were summarized for treated subjects with evaluable Cmins.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "HIV RNA Level - Treated Subjects With Evaluable Cmins at Week 24", 
                                    "units": "log10 c/mL"
                                }
                            ]
                        }, 
                        "population": "Participants with evaluable Cmins; as-randomized population (refers to the treatment regimen assigned at randomization).", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 24", 
                        "title": "HIV RNA Level - Treated Subjects With Evaluable Cmins at Week 24", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Week 24 HIV RNA level and change from baseline were summarized for treated subjects with evaluable Cmins.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "ATV 300 mg + RTV 100 mg + TDF 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 300 mg / RTV"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "ATV 400 mg + SQV 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                                    "title": "ATV 400 mg / SQV"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Week 24 HIV RNA level and change from baseline were summarized for treated subjects with evaluable Cmins.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "HIV RNA Level - Treated Subjects With Evaluable Cmins at Week 48", 
                                    "units": "log10 c/mL"
                                }
                            ]
                        }, 
                        "population": "Formal population PK/PD analysis was not performed due to difficulties in correlating time of blood sample collection with drug administration, and inability to apply the PK model generated with data obtained from healthy subjects due to newly observed differences in exposure to atazanavir between HIV-infected participants and healthy participants.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline, Week 48", 
                        "title": "HIV RNA Level - Treated Subjects With Evaluable Cmins at Week 48", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "atazanavir (ATV) 300 mg + ritonavir (RTV) 100 mg + tenofovir (TDF) 300 mg + nucleoside of choice\nATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "ATV 300 mg / RTV"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "ATV 400 mg + saquinavir (SQV) 1200 mg + TDF 300 mg + nucleoside of choice\nATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "ATV 400 mg / SQV"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "lopinavir (LPV)/RTV 400/100 mg + TDF 300 mg + nucleoside of choice\nLPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "LPV / RTV"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "10", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Adverse Event"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Death"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Disease Progression / Relapse"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "4", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "4", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "3", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "6", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "7", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Noncompliance"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Protocol Violation While on Study"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "5", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Study Termination by Sponsor"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "33", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "33", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "28", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Lack of Efficacy"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "120 randomized, 119 treated", 
                                                "@count": "119", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "115 randomized, 110 treated", 
                                                "@count": "110", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "#text": "123 randomized, 118 treated", 
                                                "@count": "118", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "26", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "29", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "13", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Discontinued Prior to Week 48 Visit"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "26", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "27", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "30", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Discontinued Between Weeks 48 and 96"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "4", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "4", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "Discontinued on or After Week 96"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "63 remained on treatment, 0 completed at Week 96", 
                                                "@count": "63", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "50 remained on treatment, 0 completed at Week 96", 
                                                "@count": "50", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "#text": "59 remained on treatment, 10 completed at Week 96", 
                                                "@count": "69", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "56", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "60", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "49", 
                                                "@group_id": "P3"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "571 human immunodeficiency virus (HIV)-infected participants were enrolled; 358 (63%) were randomized to treatment. Of the 213 not randomized, 194 did not meet eligibility criteria; other reasons include duplicate enrollment (4), accrual closed (1), noncompliance (1), serious adverse event (2), patient request (11), missing information (4)."
            }, 
            "point_of_contact": {
                "email": "Clinical.Trials@bms.com", 
                "name_or_title": "BMS Study Director", 
                "organization": "Bristol-Myers Squibb"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "atazanavir (ATV) 300 mg + ritonavir (RTV) 100 mg + tenofovir (TDF) 300 mg + nucleoside of choice ATV , RTV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "ATV300/RTV"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "ATV 400 mg + saquinavir (SQV) 1200 mg + TDF 300 mg + nucleoside of choice ATV, SQV, and TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "ATV400/SQV"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "lopinavir (LPV)/RTV 400/100 mg + TDF 300 mg + nucleoside of choice LPV/RTV twice daily, TDF once daily, nucleoside per label 48 Weeks and then for as long as subject is in need of therapy through study", 
                            "title": "LPV/RTV"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "101", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "95", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "104", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "13", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "OCULAR ICTERUS"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "23", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "30", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "NAUSEA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "16", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "VOMITING"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "30", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "34", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "63", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DIARRHOEA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DYSPEPSIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "GASTRITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "FLATULENCE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ABDOMINAL PAIN"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ABDOMINAL DISTENSION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "16", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ABDOMINAL PAIN UPPER"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "FATIGUE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PYREXIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ASTHENIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OEDEMA PERIPHERAL"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "INFLUENZA LIKE ILLNESS"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "JAUNDICE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "23", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HYPERBILIRUBINAEMIA"
                                        }
                                    ]
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "HYPERSENSITIVITY"
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "20", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "INFLUENZA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PNEUMONIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SINUSITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "BRONCHITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PHARYNGITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "GASTROENTERITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "NASOPHARYNGITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "URINARY TRACT INFECTION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "UPPER RESPIRATORY TRACT INFECTION"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LIPASE INCREASED"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "WEIGHT DECREASED"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "BLOOD BILIRUBIN INCREASED"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "BLOOD TRIGLYCERIDES INCREASED"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ASPARTATE AMINOTRANSFERASE INCREASED"
                                        }
                                    ]
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DECREASED APPETITE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HYPERTRIGLYCERIDAEMIA"
                                        }
                                    ]
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "MYALGIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "BACK PAIN"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ARTHRALGIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PAIN IN EXTREMITY"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "23", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "28", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "22", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HEADACHE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DIZZINESS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PARAESTHESIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HYPOAESTHESIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "NEUROPATHY PERIPHERAL"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ANXIETY"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "INSOMNIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DEPRESSION"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "COUGH"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OROPHARYNGEAL PAIN"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "RASH"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PRURITUS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LIPOATROPHY"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LIPODYSTROPHY ACQUIRED"
                                        }
                                    ]
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 12.1", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "22", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "22", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "19", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "LYMPHADENOPATHY"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PERICARDITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CARDIAC FAILURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CARDIAC TAMPONADE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "MYOCARDIAL INFARCTION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ACUTE MYOCARDIAL INFARCTION"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "GLAUCOMA"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "COLITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "VOMITING"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DIARRHOEA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "GASTRITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "TOOTHACHE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HAEMATEMESIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PANCREATITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "INGUINAL HERNIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ABDOMINAL PAIN LOWER"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DIARRHOEA HAEMORRHAGIC"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "INTESTINAL OBSTRUCTION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LOWER GASTROINTESTINAL HAEMORRHAGE"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CYST"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CHILLS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "MALAISE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PYREXIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CHEST PAIN"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "HEPATIC CIRRHOSIS"
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "HYPERSENSITIVITY"
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SEPSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CYSTITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PNEUMONIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SINUSITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "UROSEPSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "BRONCHITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ABSCESS LIMB"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ANAL ABSCESS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SEPTIC SHOCK"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HERPES ZOSTER"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "NEUROSYPHILIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OSTEOMYELITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CRYPTOCOCCOSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LOBAR PNEUMONIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PYELONEPHRITIS ACUTE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "GASTROENTERITIS VIRAL"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "MENINGITIS TUBERCULOUS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OESOPHAGEAL CANDIDIASIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CLOSTRIDIUM DIFFICILE COLITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "POSTOPERATIVE WOUND INFECTION"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OVERDOSE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HEAD INJURY"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HIP FRACTURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "FOOT FRACTURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "FEMUR FRACTURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SPINAL FRACTURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SUBDURAL HAEMATOMA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LOWER LIMB FRACTURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "FEMORAL NECK FRACTURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LUMBAR VERTEBRAL FRACTURE"
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "WEIGHT DECREASED"
                                    }
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DEHYDRATION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DIABETES MELLITUS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HYPERLACTACIDAEMIA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "METABOLIC ACIDOSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HYPERTRIGLYCERIDAEMIA"
                                        }
                                    ]
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OSTEONECROSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "INTERVERTEBRAL DISC PROTRUSION"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "LYMPHOMA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ANAL CANCER"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "NON-HODGKIN'S LYMPHOMA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SQUAMOUS CELL CARCINOMA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT"
                                        }
                                    ]
                                }, 
                                "title": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HEADACHE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CONVULSION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "TENSION HEADACHE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "CAROTID ARTERY STENOSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DEPRESSED LEVEL OF CONSCIOUSNESS"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DRUG ABUSE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ALCOHOL ABUSE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DRUG DEPENDENCE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "MAJOR DEPRESSION"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "SUICIDAL IDEATION"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "RENAL FAILURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "RENAL FAILURE ACUTE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "RENAL TUBULAR ACIDOSIS"
                                        }
                                    ]
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PROSTATITIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "OVARIAN CYST"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "VAGINAL PROLAPSE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "MENSTRUATION IRREGULAR"
                                        }
                                    ]
                                }, 
                                "title": "Reproductive system and breast disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DYSPNOEA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "HAEMOPTYSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "RESPIRATORY FAILURE"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "RESPIRATORY DISTRESS"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "119"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "110"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "118"
                                            }
                                        ], 
                                        "sub_title": "HOSPITALISATION"
                                    }
                                }, 
                                "title": "Surgical and medical procedures"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "ANEURYSM"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "DEEP VEIN THROMBOSIS"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "119"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "110"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "118"
                                                }
                                            ], 
                                            "sub_title": "PELVIC VENOUS THROMBOSIS"
                                        }
                                    ]
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 12.1"
                }, 
                "time_frame": "The AE data below represents data from start of study in November 2001 through the last locked database of the study, 18 November 2009."
            }
        }, 
        "completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Virologic failure to 2 or more highly active antiretroviral therapy (HAART) regimens\n             that, in total, have included at least one drug from all approved classes protease\n             inhibitors, non-nucleoside reverse transcriptase inhibitors, nucleoside reverse\n             transcriptase inhibitors (PI, NNRTI, NRTI):\n\n               1. Currently on a failing HAART regimen with 2 qualifying plasma viral load\n                  measurements (hospital/clinic value within 4 weeks of screening with viral load\n                  equivalent to =>1,000 c/mL on the Roche Amplicor[TM] and central lab\n                  measurements of =>1,000 c/mL (Roche Amplicor[TM]) within 4 weeks of\n                  randomization\n\n               2. Cluster of Differentiation 4 (CD4) cell count =>50 cells/mm3 obtained within 4\n                  weeks prior to randomization\n\n          -  =>16 years of age (or minimum age as determined by local regulations or as legal\n             requirements dictate);\n\n          -  History of prior virologic response to at least one HAART regimen, defined as a 1.0\n             log10 decline or a decline in viral load to <400 c/mL by Roche Amplicor or <500 c/mL\n             by Chiron Quantiplex branched DNA (bDNA) assay\n\n          -  Both females of child bearing potential and males must utilize effective barrier\n             contraception to reduce transmission of sexually transmitted disease, including human\n             immunodeficiency virus (HIV).  Other contraception in addition to barrier methods is\n             permitted; interaction between atazanavir and oral contraceptives has not been\n             studied.\n\n          -  Subjects must be able to provide written informed consent;\n\n          -  Subjects should be available for follow-up for a period of at least 48 weeks\n\n          -  Baseline laboratory values measured within 2 weeks prior to initiating study drugs as\n             follows:\n\n               1. serum creatine <1.5 times the upper limit of normal (ULN)\n\n               2. total serum lipase <1.4 times the ULN\n\n               3. liver enzymes alanine aminotransferase (AST), aspartate aminotransferase (ALT)\n                  <3 times the ULN\n\n               4. total serum bilirubin <1.5 times the ULN\n\n        Exclusion Criteria:\n\n          -  Prior use (=>3 days) of atazanavir, TVF or LPV/RTV; if history of SQV, then must be\n             phenotypically sensitive\n\n          -  the current failing antiretroviral regimen must have been administered for at least\n             eight weeks at he initiation of screening and must not include both a PI and NNRTI\n\n          -  Presence of a newly diagnosed HIV-related opportunistic infection or any medical\n             requiring acute therapy at the time of enrollment\n\n          -  Proven or suspected acute hepatitis in the 30 days prior to study entry.  Subjects\n             with chronic hepatitis are eligible provided that their liver function enzymes\n             (ALT/AST) are <3 x ULN\n\n          -  Previous therapy with agents with significant systemic myelosuppressive, neurotoxic,\n             pancreatoxic, hepatoxic or cytotoxic potential within 3 months of study start or the\n             expected need for such therapy at the time of enrollment of therapy with methadone or\n             ribavirin/interferons or treatment with neurotoxic drugs or drugs that affect\n             Cytochrome P450 3A4 (CYP3A4).\n\n          -  Active alcohol or substance use sufficient, in the Investigator's opinion, to prevent\n             adequate compliance with study therapy or to increase the risk of developing\n             pancreatitis or chemical hepatitis\n\n          -  Intractable diarrhea (=> 6 loose stools/day for at least 7 days consecutive days)\n             within 30 days prior to study entry\n\n          -  Pregnancy or breast-feeding\n\n          -  History of hemophilia\n\n          -  Presence of cardiomyopathy\n\n          -  Any one of the following:\n\n               1. Heart rate-corrected QT (QTc) interval >450 msec on the screening\n                  electrocardiogram (EKG)\n\n               2. Heart rate <40 beats per minute (bpm)\n\n               3. Pause length >3 seconds seen on EKG\n\n               4. Clinical symptoms potentially related to heart block\n\n               5. Third degree heart block\n\n          -  History of acute or chronic pancreatitis\n\n          -  If choosing 2'-3' dideoxyinosine (ddI) or 2',3'-didehydro-3'-deoxythymidine (d4T) as\n             the NRTI: History or signs and symptoms of bilateral peripheral neuropathy => Grade 2\n             at the time of screening\n\n          -  Inability to tolerate oral medications\n\n          -  Any other clinical conditions or prior therapy that, in the opinion of the\n             Investigator, would make the subject unsuitable for study or unable to comply with\n             the dosing requirements."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "571", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 6, 2002", 
        "firstreceived_results_date": "October 14, 2010", 
        "has_expanded_access": "Yes", 
        "id_info": {
            "nct_alias": "NCT00028054", 
            "nct_id": "NCT00035932", 
            "org_study_id": "AI424-045"
        }, 
        "intervention": [
            {
                "arm_group_label": "I", 
                "description": "Active Comparator, \tCapsules, tablets, Oral", 
                "intervention_name": "Atazanavir + ritonavir + tenofovir + nucleoside", 
                "intervention_type": "Drug", 
                "other_name": [
                    "BMS-232632", 
                    "Reyataz"
                ]
            }, 
            {
                "arm_group_label": "II", 
                "description": "Active Comparator, Capsules, tablets, Oral", 
                "intervention_name": "Atazanavir + saquinavir + tenofovir + nucleoside", 
                "intervention_type": "Drug", 
                "other_name": [
                    "BMS-232632", 
                    "Reyataz"
                ]
            }, 
            {
                "arm_group_label": "III", 
                "description": "Active Comparator, Capsules, tablets, Oral", 
                "intervention_name": "Lopinavir/ritonavir + tenofovir + nucleoside", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Saquinavir", 
                "Ritonavir", 
                "Lopinavir", 
                "Atazanavir", 
                "Tenofovir", 
                "Tenofovir disoproxil"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 29, 2010", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94121"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boulder", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80304"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Altamonte Springs", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ft Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33306"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ft Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33308"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33160"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32801"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Georgia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Honolulu", 
                        "country": "United States", 
                        "state": "Hawaii", 
                        "zip": "96816"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boise", 
                        "country": "United States", 
                        "state": "Indiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67214"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brookline", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fall River", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02720"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Orange", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07103"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14215"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manhasset", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11030"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10019"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14620"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huntersville", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28078"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "29203"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75246"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77006"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Phase III Open Label Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV", 
        "overall_official": {
            "affiliation": "Bristol-Myers Squibb", 
            "last_name": "Bristol-Myers Squibb", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2003", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Mean Change From Baseline in HIV Ribonucleic Acid (RNA) at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "measure": "Mean Change From Baseline in HIV RNA at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "measure": "Mean Change From Baseline in HIV RNA at Week 96", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 96"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00035932"
        }, 
        "responsible_party": {
            "name_title": "Study Director", 
            "organization": "Bristol-Myers Squibb"
        }, 
        "secondary_outcome": [
            {
                "measure": "Mean Change From Baseline in HIV RNA at Week 2", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 2"
            }, 
            {
                "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 24, by their baseline phenotypic sensitivity to their randomized PI.", 
                "measure": "Participants Achieving Virologic Half Log Suppression (Limit of Quantification [LOQ] = 400 c/mL) at Week 24 (Overall and by Protease Inhibitor [PI] Sensitivity)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 48, by their baseline phenotypic sensitivity to their randomized PI.", 
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 400 c/mL) at Week 48, (Overall and by PI Sensitivity)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 400 c/mL at Week 96.", 
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 400 c/mL) at Week 96", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 96"
            }, 
            {
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Week 24"
            }, 
            {
                "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 50 c/mL at Week 24, by their baseline phenotypic sensitivity to their randomized PI.", 
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 24, by PI Sensitivity", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Week 48"
            }, 
            {
                "description": "Number of participants with a >=0.5 log10 decrease in HIV RNA from baseline or HIV RNA < 50 c/mL at Week 48, by their baseline phenotypic sensitivity to their randomized PI.", 
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 48, by PI Sensitivity", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "measure": "Participants Achieving Virologic Half Log Suppression (LOQ = 50 c/mL) at Week 96", 
                "safety_issue": "No", 
                "time_frame": "Week 96"
            }, 
            {
                "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                "measure": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Week 24"
            }, 
            {
                "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                "measure": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 48", 
                "safety_issue": "Yes", 
                "time_frame": "Week 48"
            }, 
            {
                "description": "Treatment Response = confirmed suppression to LOQ (400 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                "measure": "Participants Achieving Treatment Response (LOQ = 400 c/mL) Without Prior Failure at Week 96", 
                "safety_issue": "Yes", 
                "time_frame": "Week 96"
            }, 
            {
                "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                "measure": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Week 24"
            }, 
            {
                "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                "measure": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Week 48"
            }, 
            {
                "description": "Treatment Response = confirmed suppression to LOQ (50 c/mL). The Algorithm for Treatment Response Without Prior Failure (TRPWF) = participants staying in response at the analysis timepoint without having an intervening, confirmed rebound.", 
                "measure": "Participants Achieving Treatment Response (LOQ = 50 c/mL) Without Prior Failure at Week 96", 
                "safety_issue": "Yes", 
                "time_frame": "Week 96"
            }, 
            {
                "measure": "Change From Baseline in CD4 Cell Count at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "measure": "Change From Baseline in CD4 Cell Count at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "measure": "Change From Baseline in CD4 Cell Count at Week 96", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 96"
            }, 
            {
                "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with HIV RNA change from baseline at Week 24 were explored.", 
                "measure": "Correlation of ATV Minimum Plasma Concentration (Cmin), Inhibitory Quotient (IQ), and Number of Protease Inhibitor (PI) Mutations at Baseline With HIV RNA Change From Baseline at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with HIV RNA change from baseline at Week 48 were explored.", 
                "measure": "Correlation of ATV Minimum Plasma Concentration (Cmin), Inhibitory Quotient (IQ), and Number of Protease Inhibitor (PI) Mutations at Baseline With HIV RNA Change From Baseline at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with CD4 cell count change from baseline at Week 24 were explored.", 
                "measure": "Correlation of ATV Minimum Plasma Concentration (Cmin) Inhibitory Quotient (IQ), and Number of PI Mutations at Baseline and CD4 Cell Count Change From Baseline at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "description": "Pearson correlations of the Cmin (trough plasma concentration), IQ (the ratio of Cmin of ATV to HIV IC50), and Number of baseline PI Mutations with CD4 cell count change from baseline at Week 48 were explored.", 
                "measure": "Correlation of ATV Minimum Plasma Concentration (Cmin) Inhibitory Quotient (IQ), and Number of PI Mutations at Baseline and CD4 Cell Count Change From Baseline at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                "measure": "Lipid Mean Percent Change From Baseline at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                "measure": "Lipid Mean Percent Change From Baseline at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Week 48"
            }, 
            {
                "description": "Mean percent change in total cholesterol, high density lipoprotein (HDL) cholesterol, fasting low density lipoprotein (LDL) cholesterol, and fasting triglycerides.", 
                "measure": "Lipid Mean Percent Change From Baseline at Week 96, Observed Values", 
                "safety_issue": "No", 
                "time_frame": "Week 96"
            }, 
            {
                "description": "AE=any new untoward medical occurrence/worsening of a pre-existing medical condition regardless of causal relationship. SAE=any untoward medical occurrence at any dose that: results in death; is life-threatening; requires/prolongs inpatient hospitalization; results in persistent/significant disability; is cancer; is congenital anomaly/birth defect; results in drug dependency/abuse; is an important medical event.", 
                "measure": "Deaths, Serious Adverse Events (SAEs), and Adverse Events (AEs) Through Week 48", 
                "safety_issue": "Yes", 
                "time_frame": "From Enrollment through Week 48"
            }, 
            {
                "description": "Prespecified AEs of interest included jaundice, ocular icterus, and hyperbilirubinemia.", 
                "measure": "Most Common AEs and AEs of Interest Through Week 48", 
                "safety_issue": "Yes", 
                "time_frame": "From Enrollment to Week 48"
            }, 
            {
                "measure": "Fasting Glucose Mean Change From Baseline at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "measure": "Fasting Glucose Mean Change From Baseline at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Week 48"
            }, 
            {
                "description": "Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Grades:1=Mild, 2=Moderate, 3=Severe, 4=Life-threatening/disabling, 5=Death. Abnormal values: absolute neutrophil count: \u2265500 to <750/mm3 (grade 3), <500/mm3 (grade 4); platelets: 20,000-49,999/mm3 (grade 3), <20,000/mm3 or diffuse petechiae (grade 4); alanine transaminase (ALT): 5.1-10 x upper limit of normal (ULN; grade 3), >10 x ULN (grade 4); aspartate transaminase (AST):  5.1-10 x ULN (grade 3), >10 x ULN (grade 4); bilirubin: 2.6-5 x ULN (grade 3), >5 x ULN (grade 4).", 
                "measure": "Grade 3/4 Laboratory Abnormalities Through Week 48", 
                "safety_issue": "Yes", 
                "time_frame": "From Enrollment to Week 48"
            }, 
            {
                "description": "The QT interval is a measure of the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle. The QT interval was corrected for heart rate using Fridericia's (QTcF) formula.", 
                "measure": "Fridericia-corrected QT (QTcF) Interval and Change From Baseline by Analysis Time Point", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 4 predose, 2-3 hours postdose, 6-12 hours postdose, Week 12, Week 24, Week 48"
            }, 
            {
                "description": "The PR interval is measured from the beginning of the P wave to the beginning of the QRS complex, and reflects the time the electrical impulse takes to travel from the sinus node through the atrioventricular (AV) node and entering the ventricles. The PR interval is therefore a good estimate of AV node function.", 
                "measure": "PR Interval and Change From Baseline by Analysis Time Point", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 4 predose, 2-3 hours postdose, 6-12 hours postdose, Week 12, Week 24, Week 48"
            }, 
            {
                "description": "The MACS adherence questionnaire asks patients how many medication doses they missed during the previous day, 2 days, 3 days and 4 days. Drug-specific questions included adherence with dose and frequency. Adherence was defined as taking all doses and numbers of pills as prescribed for each medication. This strict adherence cut-off was based on the guidelines stating that anything less than excellent adherence may result in a virus breakthrough and development of resistance.", 
                "measure": "Adherence to Regimen Though Week 48 Based on MACS the Multicenter AIDS Cohort Study (MACS) Adherence Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24, Week 48"
            }, 
            {
                "description": "The EQ-5D is a 5-item questionnaire to assess health-related quality of life in 5 health dimensions (mobility, self-care, usual activity, pain/discomfort, anxiety/depression) are scored on a 3-level scale: no problems (1), some problems (2), extreme problems (3). Using a standard algorithm, responses are summarized into a single score, the EQ-5D Health Index Score (HIS), which ranges between 1 (representing perfect health) and 0 (representing the worst imaginable health state or death). The smallest coefficient of change is 0.03.", 
                "measure": "Mean Score of European Quality of Life-5 Dimensions (EQ-5D) Health Index Score at Baseline, Mid-Study (Week 24), and Final (Week 48)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24, Week 48"
            }, 
            {
                "description": "The EQ-5D has a Visual Analog Scale (VAS), which is a feeling thermometer-like scale with a range between 0 and 100. Patients are required to draw a line from a box on the VAS scale to an actual mark on the thermometer-like scale that corresponds with a number that reflects their self-assessed health status at the time they are completing the questionnaire. Higher VAS scores indicate better overall health. There is no minimum clinically important difference reported in the literature for VAS.", 
                "measure": "Mean Score of European Quality of Life-5 Dimensions (EQ-5D) Visual Analog Scale (VAS) at Baseline, Mid-Study (Week 24), and Final (Week 48)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24, Week 48"
            }, 
            {
                "description": "Participants' overall resource utilization for managing lipid elevation that includes the management of side effects of lipid lowering medications, such as those due to drug interactions.", 
                "measure": "Number of Participants Utilizing Resources for Managing Lipid Elevation", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24, Week 48"
            }, 
            {
                "description": "The minimum or \"trough\" concentration (Cmin) of a drug observed after its administration and just prior to the administration of a subsequent dose.", 
                "measure": "Mean ATV, RTV and SQV Minimum Concentration (Cmin) Values", 
                "safety_issue": "No", 
                "time_frame": "collected at the pre-dose time point after receiving atazanavir for at least four weeks"
            }, 
            {
                "description": "IC50:   inhibitory concentration of drug required to reduce viral replication by 50%.", 
                "measure": "HIV IC50 at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Week 24"
            }, 
            {
                "description": "Inhibitory quotient is a measure of drug exposure and susceptibility in an individual. The IQ is typically calculated as the ratio of Cmin to HIV IC50.", 
                "measure": "Inhibitory Quotient at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "description": "Inhibitory quotient is a measure of drug exposure and susceptibility in an individual. The IQ is typically calculated as the ratio of Cmin to HIV IC50.", 
                "measure": "Inhibitory Quotient at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }, 
            {
                "description": "Week 24 HIV RNA level and change from baseline were summarized for treated subjects with evaluable Cmins.", 
                "measure": "HIV RNA Level - Treated Subjects With Evaluable Cmins at Week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 24"
            }, 
            {
                "description": "Week 24 HIV RNA level and change from baseline were summarized for treated subjects with evaluable Cmins.", 
                "measure": "HIV RNA Level - Treated Subjects With Evaluable Cmins at Week 48", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 48"
            }
        ], 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2010"
    }, 
    "geocoordinates": {
        "null": "29.76 -95.369"
    }
}